Article Details
Retrieved on: 2021-10-21 05:54:16
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(OTCQB: CYDY) ("CytoDyn" or the "Company"), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for ...
Article found on: finance.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here